Cards Acccepted | 5% OFF Crypto | 3rd Party Testing | FREE Worldwide Shipping $400+
Menu
Cart
mazdutide 5 mg vial
lyophilized peptide vial box (white cap)
mazdutide certificate of analysis
mazdutide hplc

Mazdutide 5mg – 10 Vial Box (50mg Total)

$300.0

Cost per vial $: 30

Buy mazdutide 5 mg (one 10-vial box). All orders are shipped wholesale in unbranded packaging. Worldwide 7 – 14 day shipping to the USA, UK, AUS & NZ.

Bulk discounts
QuantityBulk DiscountPrice
210%$270.0
3-515%$255.0
6-1020%$240.0
SKU: MAZ5Category:

Description

Mazdutide is a synthetic glucagon-like peptide designed to mimic natural hormones that play a role in regulating appetite and metabolism. It works by targeting two receptors in the body, GLP-1 and glucagon, and is currently being researched as a potential treatment for obesity and type-2 diabetes. Mazdutide is the generic peptide version of OXM3.

Minimum order quantity: one box (10 vials x 5 mg).

Note: Product images show branded labels for illustration purposes only. All peptides are shipped in wholesale, unbranded packaging. You can see an actual example photo of the peptide vials and container above.

Additional information

Purity

≥99.0%

Molar Mass

4476 g/mol

Molecular Formula

C₂₀₇H₃₁₇N₄₅O₆₅

Sequence

His-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Glu-Lys-Lys-Ala-Lys-{AEEA-AEEA-γGlu-Nonadecanoic acid}-Glu-Phe-Val-Glu-Trp-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-NH2

  1. Nalisa, David Lubasi, et al. "Efficacy and safety of Mazdutide on weight loss among diabetic and non-diabetic patients: a systematic review and meta-analysis of randomized controlled trials." Frontiers in Endocrinology 15 (2024): 1309118.
  2. JI, LINONG, et al. "1856-LB: Efficacy and Safety of Mazdutide in Chinese Participants with Overweight or Obesity (GLORY-1)." Diabetes 73.Supplement_1 (2024).
  3. JIANG, HONGWEI, et al. "1866-LB: A Phase 2 Study of Mazdutide 9 mg in Chinese Adults with BMI of 30 kg/m2 or more." Diabetes 73.Supplement_1 (2024).
  4. Gogineni, Prathima, et al. "Oral glucagon-like peptide-1 receptor agonists and combinations of entero-pancreatic hormones as treatments for adults with type 2 diabetes: where are we now?." Expert Opinion on Pharmacotherapy just-accepted (2024).
  5. Deng, Bixin, et al. "Safety and efficacy of GLP-1 and glucagon receptor dual agonist for the treatment of type 2 diabetes and obesity: a systematic review and meta-analysis of randomized controlled trials." Endocrine (2024): 1-13.
  6. Zhang, Bo, et al. "Efficacy and safety of mazdutide in chinese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled phase 2 trial." Diabetes care 47.1 (2024): 160-168.

Mazdutide CoA 2024

Mazdutide HPLC

Related products